BDNF and Alzheimer disease: We can therefore suppose that the increased serum levels of BDNF and NGF observed in patients with advanced glaucomatous damage compared to those of patients with early and moderate glaucoma and similar to those of healthy subjects could be explained with the same compensatory repair model described in patients with advanced Alzheimer’s disease [26,27].